Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP482336.RAa8IO6BmQSc5ZjPzkTYtfwYK-dvTtE2m-dLnNAlyQ0PQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP482336.RAa8IO6BmQSc5ZjPzkTYtfwYK-dvTtE2m-dLnNAlyQ0PQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP482336.RAa8IO6BmQSc5ZjPzkTYtfwYK-dvTtE2m-dLnNAlyQ0PQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP482336.RAa8IO6BmQSc5ZjPzkTYtfwYK-dvTtE2m-dLnNAlyQ0PQ130_provenance.
- NP482336.RAa8IO6BmQSc5ZjPzkTYtfwYK-dvTtE2m-dLnNAlyQ0PQ130_assertion description "[We suggest that TGF-? induces SREBP-2 pathway activation through ITGAV and PI3K playing a key role in OA and that integrin blockage may be a potential molecular target for OA treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP482336.RAa8IO6BmQSc5ZjPzkTYtfwYK-dvTtE2m-dLnNAlyQ0PQ130_provenance.
- NP482336.RAa8IO6BmQSc5ZjPzkTYtfwYK-dvTtE2m-dLnNAlyQ0PQ130_assertion evidence source_evidence_literature NP482336.RAa8IO6BmQSc5ZjPzkTYtfwYK-dvTtE2m-dLnNAlyQ0PQ130_provenance.
- NP482336.RAa8IO6BmQSc5ZjPzkTYtfwYK-dvTtE2m-dLnNAlyQ0PQ130_assertion SIO_000772 22662110 NP482336.RAa8IO6BmQSc5ZjPzkTYtfwYK-dvTtE2m-dLnNAlyQ0PQ130_provenance.
- NP482336.RAa8IO6BmQSc5ZjPzkTYtfwYK-dvTtE2m-dLnNAlyQ0PQ130_assertion wasDerivedFrom befree-20140225 NP482336.RAa8IO6BmQSc5ZjPzkTYtfwYK-dvTtE2m-dLnNAlyQ0PQ130_provenance.
- NP482336.RAa8IO6BmQSc5ZjPzkTYtfwYK-dvTtE2m-dLnNAlyQ0PQ130_assertion wasGeneratedBy ECO_0000203 NP482336.RAa8IO6BmQSc5ZjPzkTYtfwYK-dvTtE2m-dLnNAlyQ0PQ130_provenance.
- befree-20140225 importedOn "2014-02-25" NP482336.RAa8IO6BmQSc5ZjPzkTYtfwYK-dvTtE2m-dLnNAlyQ0PQ130_provenance.